News
Please, enter cell line, author or any other phrase or word you would like to search for.
Year-end Report 2019/20
To emerge stronger from the pandemic than entering it, we have for the time being focused our resources on reducing sales cost, improving our market visibility and expanding the HoloMonitor product line.
National Institute on Aging and PHI sign collaboration agreement
The National Institute on Aging and PHI recently entered a collaboration agreement, aiming to develop an add-on fluorescent module for PHI’s HoloMonitor imaging cytometer.
PHI secure working capital until 2022
To bridge and adapt to the consequences of the COVID-19 pandemic, PHI has received a binding credit facility of 15 MSEK.
Interim Report 3 2019/20
With permanent staff on the ground in the US, we will be able to prepare, train and support a US sales organization much more efficiently than what was previously achievable.
Gladstone Institutes, University of California and PHI form joint Center of Excellence
Gladstone Institutes, University of California in San Francisco and PHI recently formed San Francisco’s Center of Excellence for Holographic Imaging Cytometry.
CEO interview in BioStock
In the article published today by BioStock, the company’s CEO Peter Egelberg comments on the developments during the past autumn.
New CEO commentary: “The Single-Cell Revolution”
PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization.
Interim Report 2 2019/20
Interim Report 2 (2019-05-01 – 2019-10-31) from Phase Holographic Imaging.
New SelectScience eBook helps scientists choose the best cell imaging technology
A new cell imaging technology guide has been launched by leading independent science publisher SelectScience® to help scientists find the best equipment for their applications.
Interim Report 1 2019/20
Interim Report 1 (2019-05-01 – 2019-07-31) from Phase Holographic Imaging.